These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 21938539)
21. Two cases of fulminant colitis due to binary toxin-positive Clostridium difficile that are not PCR ribotype 027 or type 078. Tagashira Y; Kato H; Senoh M; Nakamura A J Med Microbiol; 2013 Sep; 62(Pt 9):1486-1489. PubMed ID: 23558137 [TBL] [Abstract][Full Text] [Related]
22. Predicting recurrence of C. difficile colitis using bacterial virulence factors: binary toxin is the key. Stewart DB; Berg A; Hegarty J J Gastrointest Surg; 2013 Jan; 17(1):118-24; discussion p.124-5. PubMed ID: 23086451 [TBL] [Abstract][Full Text] [Related]
23. Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China. Du P; Cao B; Wang J; Li W; Jia H; Zhang W; Lu J; Li Z; Yu H; Chen C; Cheng Y J Clin Microbiol; 2014 Sep; 52(9):3264-70. PubMed ID: 24958798 [TBL] [Abstract][Full Text] [Related]
24. Detection and elimination of a novel non-toxigenic Maslanka JR; Gu CH; Zarin I; Denny JE; Broadaway S; Fett B; Mattei LM; Walk ST; Abt MC Gut Microbes; 2020 Nov; 12(1):1-15. PubMed ID: 33305657 [No Abstract] [Full Text] [Related]
25. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays. Pancholi P; Kelly C; Raczkowski M; Balada-Llasat JM J Clin Microbiol; 2012 Apr; 50(4):1331-5. PubMed ID: 22278839 [TBL] [Abstract][Full Text] [Related]
27. Genomic and phenotypic studies among Meléndez-Sánchez D; Hernández L; Ares M; Méndez Tenorio A; Flores-Luna L; Torres J; Camorlinga-Ponce M Microbiol Spectr; 2024 Jul; 12(7):e0394723. PubMed ID: 38864670 [No Abstract] [Full Text] [Related]
28. First genotypic characterization of toxigenic Clostridioides difficile in Lithuanian hospitals reveals the prevalence of the hypervirulent ribotype 027/ST1. Tratulyte S; Miciuleviciene J; Kuisiene N Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1953-1959. PubMed ID: 31327067 [TBL] [Abstract][Full Text] [Related]
29. Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America. Aguayo C; Flores R; Lévesque S; Araya P; Ulloa S; Lagos J; Hormazabal JC; Tognarelli J; Ibáñez D; Pidal P; Duery O; Olivares B; Fernández J Epidemiol Infect; 2015 Oct; 143(14):3069-73. PubMed ID: 25687254 [TBL] [Abstract][Full Text] [Related]
30. Perirectal swab surveillance for Clostridium difficile by use of selective broth preamplification and real-time PCR detection of tcdB. Curry SR; Schlackman JL; Hamilton TM; Henderson TK; Brown NT; Marsh JW; Shutt KA; Brooks MM; Pasculle AW; Muto CA; Harrison LH J Clin Microbiol; 2011 Nov; 49(11):3788-93. PubMed ID: 21880961 [TBL] [Abstract][Full Text] [Related]
31. Predominance of Clostridioides difficile PCR ribotype 181 in northern Greece, 2016-2019. Kachrimanidou M; Metallidis S; Tsachouridou O; Harmanus C; Lola V; Protonotariou E; Skoura L; Kuijper E Anaerobe; 2022 Aug; 76():102601. PubMed ID: 35688364 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital. Babady NE; Stiles J; Ruggiero P; Khosa P; Huang D; Shuptar S; Kamboj M; Kiehn TE J Clin Microbiol; 2010 Dec; 48(12):4519-24. PubMed ID: 20943860 [TBL] [Abstract][Full Text] [Related]
33. Performance assessment of the BD MAX Cdiff assay in comparison to Xpert C. difficile assay in a setting with very low prevalence of toxigenic Clostridium difficile PCR ribotype 027. Chiang D; Ng S; La MV; Jureen R; Lin RT; Teo JW Anaerobe; 2014 Dec; 30():156-8. PubMed ID: 25305151 [TBL] [Abstract][Full Text] [Related]
34. Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens. Wroblewski D; Hannett GE; Bopp DJ; Dumyati GK; Halse TA; Dumas NB; Musser KA J Clin Microbiol; 2009 Jul; 47(7):2142-8. PubMed ID: 19403775 [TBL] [Abstract][Full Text] [Related]
35. An unusual cause of false-positive results with the BD GeneOhm Cdiff assay. Louie L; Wong H; Mubareka S; Simor AE J Clin Microbiol; 2013 Apr; 51(4):1348-9. PubMed ID: 23345300 [No Abstract] [Full Text] [Related]
36. Association between Clostridioides difficile ribotypes, restriction endonuclease analysis types, and toxin gene expression. Watanabe H; Koizumi Y; Matsumoto A; Asai N; Yamagishi Y; Mikamo H Anaerobe; 2018 Dec; 54():140-143. PubMed ID: 30201540 [TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552 [TBL] [Abstract][Full Text] [Related]
38. Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile. Li Z; Ouyang Z; Zhang H; Mi C; Dong N; Niu Y; Qiang C; Yang J; Wang W; Li Y; Zhao J Clin Chim Acta; 2024 Jun; 559():119728. PubMed ID: 38750779 [TBL] [Abstract][Full Text] [Related]
39. Clinical and laboratory evaluation of a real-time PCR for Clostridium difficile toxin A and B genes. de Jong E; de Jong AS; Bartels CJ; van der Rijt-van den Biggelaar C; Melchers WJ; Sturm PD Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2219-25. PubMed ID: 22327373 [TBL] [Abstract][Full Text] [Related]